Novel synthesis of 7-β-D-Ribofuranosyl-7H-1,2,4-triazolo[3,4-i]purines with use of NBS

Synthetic Communications

Volumn 36, Issue 4, 2006, Pages 445-450

  Chen, Huijun ^a   Shang, Zhenhua ^a   Chang, Junbiao ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

7H 1,2,4 triazolo 3,4 i purine; NBS; Xanthine dehydrogenase (XDH); Xanthine oxidase (XO)

Indexed keywords

7 BETA DEXTRO RIBOFURANOSYL 7H 1,2,4 TRIAZOLO[3,4 I]PURINE; HYDRAZONE DERIVATIVE; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DRUG SYNTHESIS;

EID: 31744433525     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910500383501     Document Type: Article

References (15)

1. (a) Many, A.; Westerhousen-Larson, A.; Kanbour-Shakir, A.; Roberts, J. M. Xanthine dehydrogenase/oxidase in human placenta: Protective enzyme activity inhibition is post translationally regulated. J. Soc. Gynecol. Investig. 1995, 2, 286;
2. (b) Many, A.; Roberts, J. M. Xanthine oxidase activity is present in human placenta. J. Soc. Gynecol Investig. 1996, 3, 221A;
3. (c) Many, A.; Hubel, C. A.; Roberts, J. M. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Int. J. Gynecol. Obstet. 1996, 54, 214.
4. Fields, M.; Lewis, C. G.; Lure, M. D. Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose. Free Radic. Biol. Med. 1996, 20, 595.
5. (a) Horiuchi, H.; Ota, M.; Nishimura, S.; Kaneko, H.; Kasahara, Y.; Ohta, T. Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice. Life Sci. 2000, 66, 2051;
6. (b) Pancheva, S. N.; Venkova, T. Allopurinol potentiates the activity of vidarabine against herpes simplex virus in vitro. Antivir. Res. 1996, 30, A47.
7. (a) Tomohisa, N.; Hiroo, Y.; Toshihiko, A.; Sachiko, H.; Kenya, M.; Hitoshi, K. Facile and general syntheses of 3-and/or 5-substituted 7-β-D-ribofuranosyl-7H[1,2,4]triazolo[3,4-i]purines as a new class of potential xanthine oxidase inhibitors. Synthesis 1999, 4, 655;
8. (b) Tomohisa, N.; Hiroo, Y.; Takayuki, F.; Kazuki, E.; Haruhiko, M. Novel xanthine oxidase inhibitor studies. Part 2. Synthesis and xanthine oxidase inhibitory activities of 2-substituted 6-alkyl-idenehydrazine- or 6-arylmethylidenehydrazino-7H-purines and 3- and/or 5-substituted 9H-1,2,4-triazolo[3,4-i]purines. J. Chem. Soc., Perkin Trans. 1 1999, 3117.
9. Guillot, N.; Viehe, H. G.; Tinant, B.; Declercq, J. P. A mild and regiospecific synthesis of 3-amino substituted triazolo-[3,4-c]-pyrimidines by cyclisation of 4-hydraazinopyrimidines with iminium chlorides and with n-aryl phosgenimines. Tetrahedron 1990, 46, 3897.
10. Junichi, S.; Fumio, S. Facile synthesis of 9H-s-triazolo-[3,4-i]purin- 5(6H)-ones. Tetrahedron Lett. 1992, 33, 3151.
11. Giuliana, B.; Irene, G.; Oreste, L.; Clementina, M.; Valerio, S. 1,2,3-Triazolo[4,5-e]-1,2,4-triazolo[3,4-c]pyrimidines. J. Heterocycl. Chem. 1999, 36, 1195.
12. Irena, M.; Bojan, V. Synthesis of benzoylaminomethyl and aminomethyl substituted fused 1,2,4-triazoles. Synth. Commun. 2001, 31, 1511.
13. (a) Anil, K. S.; Yasmin, M.; Kamal, R. A.; Om, P. Hypervalent iodine mediated synthesis of 1-aryl/hetryl-1,2,4-triazolo[4,3-a]pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3-a]quinolines as antibacterial agents. Eur. J. Med. Chem. 2003, 38, 533;
14. (b) Om, P.; Rajesh, K. S.; Devinder, K.; Shiv, P. S. Hypervalent iodine in the synthesis of bridgehead heterocycles: A new synthesis of 3,5-diarylthiazolo[2,3-c]-s-triazoles. Synth. Commun. 1995, 25, 3363.
15. Ahmad, S. S.; Sobhi, M.; Gomha. Egioselectivity in 1,5-electrocyclization of N-[as-triazin-3-yl]nitrilimines. Synthesis of s-triazolo[4,3-b]-as-triazin- 7(8H)-ones. Tetrahedron 2002, 58, 8559.